We are live on ! Find out more
MYOV

Myovant Sciences Ltd.
MYOV

Delisted

MYOV was delisted on the 9th of March, 2023.

Back to rankings

36 hedge funds and large institutions have $628M invested in Myovant Sciences Ltd. in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 6

6% more funds holding

Funds holding: 34 → 36 (+2)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

17% less capital invested

Capital invested by funds: $756M → $628M (-$129M)

Holders
36
Holders Change
+2
Holders Change %
+5.88%
% of All Funds
0.82%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
8
Increased
8
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AAP
Ardsley Advisory Partners
Connecticut
+$1.34M
2
SCM
Sio Capital Management
New York
+$980K
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$623K
4
BB
BB Biotech
Switzerland
+$402K
5
State Street
State Street
Massachusetts
+$226K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$6.2M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.25M
3
SSA
Schonfeld Strategic Advisors
New York
-$1.03M
4
GPP
Great Point Partners
Connecticut
-$905K
5
Millennium Management
Millennium Management
New York
-$411K
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
26
PNC Financial Services Group
Pennsylvania
$22K – – –
Bank of America
27
Bank of America
North Carolina
$19K +$228 +17 +1%
Morgan Stanley
28
Morgan Stanley
New York
$9K -$26K -1,938 -74%
TA
29
Teachers Advisors
New York
$9K +$5.03K +375 +106%
PO
30
Private Ocean
California
$9K +$9.39K +700 New
Macquarie Group
31
Macquarie Group
Australia
$8K +$8.04K +600 New
MAM
32
Meeder Asset Management
Ohio
$1K -$1.78K -133 -62%
Citigroup
33
Citigroup
New York
$1K – – –
BNP Paribas Financial Markets
34
BNP Paribas Financial Markets
France
$190 – – –
DM
35
Deerfield Management
New York
– -$6.2M -400,685 Closed
Point72 Asset Management
36
Point72 Asset Management
Connecticut
– -$1.25M -81,100 Closed
SSA
37
Schonfeld Strategic Advisors
New York
– -$1.03M -66,900 Closed
Renaissance Technologies
38
Renaissance Technologies
New York
– -$383K -24,759 Closed
Deutsche Bank
39
Deutsche Bank
Germany
– -$260K -19,379 -100%
UBS Group
40
UBS Group
Switzerland
– -$18K -1,184 Closed
CSS
41
Cubist Systematic Strategies
Connecticut
– -$3K -183 Closed
1
2

MYOV Hedge Fund Activity: Q4 2017 in Review

36 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q4 2017, worth a combined $628M — down 17% from $756M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MYOV positions and 6 closed out — a net gain of 2 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Ardsley Advisory Partners, opening a new position worth an estimated $1.34M. The largest seller was Deerfield Management, exiting entirely with an estimated $6.2M sold.

  • 36 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q4 2017, up from 34 in Q3 2017.
  • Funds reported $628M of Myovant Sciences Ltd. stock for Q4 2017, down 17% quarter-over-quarter.
  • 8 funds opened new Myovant Sciences Ltd. positions in Q4 2017 and 6 closed out, a net change of +2 holders.
  • The largest Myovant Sciences Ltd. buyer in Q4 2017 was Ardsley Advisory Partners, an estimated $1.34M added.
  • The largest Myovant Sciences Ltd. seller in Q4 2017 was Deerfield Management, an estimated $6.2M sold.

Based on aggregated 13F filings for Q4 2017.